Stelerix Web Blog Knowledge at your Fingertips

17Feb/110

Report Giveaway – This Week Only!!

It's a $119.00 Value, for free!! We engaged over 1500 industry professionals in India and North America.

Get a thorough picture of what it takes to win in India. Forward it to your friends and get an exclusive mini-report, packed with primary research!

You can check out the Table of Contents, and download the report here!!

Posted by Jeff

9Feb/110

A New Paradigm

It can be tough to sit down and watch a 40 minute interview. People don't have time to make dinner, how are they going to have time to watch something so encompassing?

With that in mind, I've begun breaking down my work into bite-size video portions. I'll post them here, and update the pages on the main site concurrently.

In this short clip, my friend Dr. Gregory Weiss talks about a new paradigm in translational medicine and drug development, based on a comprehensive, global, or combinatorial approach. Watch and learn!

Posted by Jeff

25Jan/110

Patient Retention and Recruitment

I was lucky enough to catch up with Melynda Geurts, Chief Operating Officer at D. Anderson & Company (DAC). As a leading service provider, the DAC team leverages clinical trial expertise, creative acumen and site management excellence to produce measurable results.

DAC is scheduled to be appearing at a couple of upcoming conferences, so I kept it brief and honed in on the critical things to remember, in terms of effective clinical outsourcing and patient recruitment strategies, like, why it's worth remembering in the first place.

18Jan/110

Exclusive On-Demand Webinar, Free! Atul Sharma – Global Partnerships

If you have not yet read or listened, check this out!

Atul Sharma, Senior Manager at Alembic Limited took some time to speak with me about his expansive experiences in a diverse array of emerging and mature markets.

We discuss a number of issues in-depth, like understanding local success drivers and why innovation is especially important in generic formulations.

There are lots more similar interviews coming up, so submit your questions if you want to hear from experts!

Posted by Jeff

13Jan/110

Call for Questions!

I have a number of interviews coming up.  I am really excited to have the opportunity to speak to experienced stakeholders. It is bound to be one engaging and informing discussion after another.

Get ready for a flood of quality content in the latter half of next week.

I have done my best to think up intriguing questions. They are all based on direct input from our preliminary research and direct industry stakeholder input, like this. But I'm still new to the interview game. So if you have ideas or are burning for answers, please send them to us!

If you could pick the brain of an emerging market expert, what would you ask?

If you need some inspiration, here are some tried and true questions (and answers).

Alok Kumar, Part 1, Part 2 (FREE On-Demand webinar)

Vivek Varma - Contract Manufacturing

Posted by Jeff

12Jan/110

Exclusive Interview, Part 2

I woke up at 3:30am (2:00pm IST) the other day, to find out about lessons learned  in competitive generic global product launches.

The follow-up to our first exclusive interview is now online.

Watch this FREE, on-demand webinar to understand:

  • What the Indian market will look like in ten years
  • What differentiates it from
  • Strategies for generics success.
  • How to deal with regulatory hurdles and surprises.

It's our first attempt at supplementing an audio call with powerpoint presentations and a full minute-by-minute note-guide. We are very eager to improve and should have a version with improved sound quality up by tomorrow. Your comments and thoughts are encouraged.

FREE On-Demand Webinar - Alok Kumar discusses what is required for generics success in India, and the world.

Posted by Jeff

11Jan/110

Local Savvy

Here's an excerpt from our recent premium research:

"Of course, respondents identified active engagement of local people as the most effective means to understand their respective needs, as well as what they are able to pay to address them. However, our research also suggested that organizations as a whole have been slow to engage end-users actively. Patience and value on the long term was also a key trend among respondents. It was evident from our results that success in India favors ongoing and long-term relationships that grow and evolve over time. It is clear that the initial time investment and requisite patience were rewarded many times over in the longer term"

It's interesting, given some recent developments in the news.

Despite minor analytical shortcomings, the researchers identified different factors influencing prescription in a number of regions. It's evident that local stakeholder engagement is critical as our research said.

Alternatively, big pharma can continue to acquire leading domestic players. Abbott complemented it's own internal efforts by buying up Piramal. It plans to let the business operate independently with current management; a robust strategy, judging by our research.

We touch more on the subject of how to successfully partner with local influences and key opinion leaders in our follow-up interview with Alok Kumar (original here). It will be an audio presentation supplemented with powerpoint slides, available soon!

Sign up for our newsletter to be kept up to date!

Posted by Jeff

6Jan/110

Merck Moves In

It is always encouraging to see the big players making aggressive moves into a market. The announcement then, that Merck KgaA is setting up an Indian technology centre to provide contract development services for a large range of applications, is exactly what we like to hear. That it's part of an ongoing initiative is even more exciting.

Some of Merck's other innovative initiatives, such as the one below, present very interesting soft opportunities that will also benefit rising executives in emerging markets. And not just in job-specific technical roles. Access to the seasoned experiences of others is something that we predicate our own business on (see: interviews with experts) and another hidden benefit of globalization.

Posted by Jeff

UPDATE: Brought to our attention by our good friend, @andrealmarch is this fantastic Globe and Mail article: Ten tips for success in India

5Jan/110

Clinical Trial Site Selection

It's interesting to see talk about the shifting preference of clinical trial sites. While India has compelling advantages, other opportunities are evidently making themselves apparent. An understanding of the driving issues behind this development is incredibly helpful, and described effectively in the linked article.

The idea is of particular interest to us and our survey respondents. Our primary research has shown time and again that pharma executives have limited resources and will be stringent in deploying them, such that only the most advantageous new markets benefit.

Further developments of this nascent trend are something that we will keep a close ear to the ground for...

21Dec/100

New Year, Old Story.

It's not a new problem. Rather, a tired old refrain. It's no surprise then, that the  EMA predicts only the most modest of increases when it comes to number of new drug applications.  So another year goes by, and big pharma fails to boost it's R&D productivity. The cost to submit new drugs continues to increase, meanwhile.

Our own primary research identified this as an obvious concern. But we also found there is lots that pharma is doing to  boost revenues, outside of developing, manufacturing, and distributing new drugs. India and other emerging markets present an incredibly exciting opportunity to leverage existing products and increase brand awareness in high-growth areas. Partnerships and in-licensing agreements allow for increased reach. But problems about effective partner selection and management remain.

What's more, as the cost of doing business continues to rise, leading organizations will adapt and find flexible solutions to lower the cost of sale, our survey respondents concurred. Clinical trial outsourcing, contract manufacturing, and business process outsourcing are all being utilized by top industry contenders to keep padded, to the utmost extent.

Additional commentary is available here.

Posted by Jeff

Page 1 of 212